decisionhealth Newsletters, Coder Pink Sheets - 2004 Issue 11 (November)
You may need to track primary and secondary site ICD-9s for cancer
Subscribe or sign in to view the full article.
Article Overview
This short coding article discusses how neoplasm claims may require tracking both primary and secondary cancer sites under ICD-9-CM. It is aimed at coding and billing professionals, especially in specialty practices that see metastatic disease, and it highlights why site selection and diagnosis placement on a claim can matter without providing a full coding policy. The piece also references guidance from coding professionals and a physician-practice management organization.
Why This Topic Matters
Accurate identification of primary versus secondary cancer sites affects claim clarity and can influence how diagnoses are represented for patients with metastatic disease.
What You Will Learn
- How ICD-9-CM distinguishes broad categories of malignant neoplasms
- Why cancer cases may involve more than one diagnosis site on a claim
- Why metastatic disease creates special documentation and reporting considerations
- How specialty practices may approach primary and secondary cancer site reporting at a high level
Who Should Read This
- Medical coders
- Billing staff
- Cancer registry staff
- Physician practice managers
- Urology practice staff
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com